The measurement of urinary taurine and the liver specific enzymes AST and GGT in sheep
with hepatic damage was undertaken to determine if urinary taurine could be used as a
biomarker of hepatic damage.
Two treatment groups (n = 5) were treated with O.125ml/Kg BW of carbon tetrachloride
(CCl₄) (Group A), and O.125mg/Kg BW/day of sporidesmin (SPDM) (Group B) respectively.
Two other treatment groups (n = 4) were used as control groups. One group was placed on a
restricted diet and treated with O.625ml/Kg BW of paraffin (Group C), the other group was
not dosed (Group D).
Following dosing blood and urine samples were taken every 12 h for five days, before
weekly sampling commenced. On day 27 animals in group A were redosed with CCl₄ , due to
insignificant liver damage in this group. Blood and urine samples were again taken every 12h
for 5 days, then sampling occurred weekly until the end of the trial, when all animals, except
group D animals, were sacrificed. Tissue samples were then from liver, kidney, and
pancreatic tissue, for metal analysis, and the livers were scored for liver damage.
Liver specific enzyme activity increased in group A animals after second dosing. Enzyme
activity did not increase in group B animals, even though animals' livers demonstrated
fibrosis. Urinary taurine output was patchy and inconsistent with no conclusions able to be
reached about this data.
Results are inconclusive, with there being no indication of the effectiveness of urinary
taurine as a biomarker of liver damage.[Show full abstract]
![[PDF]](/themes/LURA/images/mimes/b_pdf.png "PDF file"){kind=small}
